3081. [Evaluation of screening tests using methylcholanthrene-sarcoma].3082. [Evaluation of antineoplastic agents by INK and MNG methods].3083. [Effect of Bleomycin on the chromosome of HeLa cells].3084. [Potentiation of the effects of antineoplastic agents].3085. [The studies on anerobic glycolysis and the inhibition of lactic acid production in Ehrlich's ascites carcinoma by anticancer agents].3086. [Cancer chemotherapy and blood coagulation-fibrinolysis system].3087. [Squamous cell carcinoma and its specificity].3088. [Present and the future cancer chemotherapy].3089. [Chemotherapy of laryngeal cancer--some problems related to its application].3090. [Chemotherapy of laryngeal cancer: effect of Bleomycin on laryngeal cancer].3091. [Effect of chemical ovulation inducing substances on gonadotropin secretion in the experiment of the anterior pituitary incubation].3092. [Pulmonary lesions produced by antitumor drugs--studies on autopsy cases].3094. [Administration of Bleomycin in cancer of the female sex organs and the follow-up results].3095. [Clinical effects of bleomycin on tumors of the head and neck].3097. [Clinical studies of the method of application of antineoplastic agents].3098. [Case of pneumonitis caused by bleomycin in the early stage of treatment].3099. [Effect of bleomycin on laryngeal cancer--compilation of the nation-wide statistics].3100. [Clinical study of hypophyseal luteinizing hormone secretion caused by F 6066 and Clomid]. |